“ATTAX: Randomised phase II study evaluating weekly docetaxel-based chemotherapy combinations in advanced esophago-gastric cancer, final results of an AGITG trial”. - Tebbutt,N.; Sourjina,T. (J Clin Oncol, ASCO Annual Meeting Proceedings Part I, 2007)